The estimated 1-year rate of ischemic stroke after implantation of the Watchman left atrial appendage (LAA) closure device (Boston Scientific) was 1.53% in its first few years of commercial use in the ...
MIAMI, July 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced the official commercial launch of the ...
SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, a revolutionary Direct-to-Intervention healthcare company, today announced that Conrad Yiu has been named as its Chief Commercial Officer (CCO). As CCO, Yiu has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results